XML 42 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity - USD ($)
$ in Thousands
Total
At-the-Market Offering
July Public Offering
Conversion of Convertible Preferred Stock
Conversion of Convertible Debt
Common Stock
Common Stock
Reverse Recapitalization
Common Stock
July Public Offering
Common Stock
Conversion of Convertible Preferred Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
July Public Offering
Additional Paid-in Capital
Conversion of Convertible Preferred Stock
Additional Paid-in Capital
Conversion of Convertible Debt
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total Convertible Preferred Stock
Balance at beginning of period (in shares) at Dec. 31, 2022                                 4,997,920
Beginning balance at Dec. 31, 2022                                 $ 111,060
Increase (Decrease) in Temporary Equity [Roll Forward]                                  
Conversion of preferred stock (in shares)                                 (4,997,920)
Conversion of preferred stock                                 $ (111,060)
Balance at end of period (in shares) at Dec. 31, 2023                                 0
Ending balance at Dec. 31, 2023                                 $ 0
Balance at beginning of period (in shares) at Dec. 31, 2022           320,281                      
Balance at beginning of period at Dec. 31, 2022 $ (102,145)         $ 3       $ 0 $ 4,860       $ 0 $ (107,008)  
Treasury stock, beginning balance (in shares) at Dec. 31, 2022                   0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Exercise of stock options (in shares)           16,349                      
Exercise of stock options 127         $ 1         126            
Vesting of restricted common stock (in shares)           5,310 41,005                    
Vesting of restricted common stock 67                   67            
Conversion of preferred stock (in shares)                 4,997,920                
Conversion of preferred stock       $ 111,060 $ 10,027       $ 50       $ 111,010 $ 10,027      
Issuance of common stock, net of issuance costs (in shares)           3,012,854                      
Issuance of common stock, net of issuance costs 19,526         $ 30         19,496            
Return of common stock to pay withholding taxes on restricted stock (in shares)                   (14,455)              
Return of common stock to pay withholding taxes on restricted stock (150)                 $ (150)              
Issuance of common stock related to stock purchase agreement (in shares)           1,213,000                      
Issuance of common stock related to stock purchase agreement 6,999         $ 12         6,987            
Issuance of common stock related to service agreement (in shares)           11,459                      
Issuance of common stock related to service agreement 75                   75            
Stock-based compensation 1,179                   1,179            
Foreign currency translation adjustment (197)                           (197)    
Net loss $ (35,195)                             (35,195)  
Balance at end of period (in shares) at Dec. 31, 2023 9,603,723         9,618,178                      
Balance at end of period at Dec. 31, 2023 $ 11,373         $ 96       $ (150) 153,827       (197) (142,203)  
Treasury stock, ending balance (in shares) at Dec. 31, 2023 (14,455)                 (14,455)              
Balance at end of period (in shares) at Dec. 31, 2024                                 0
Ending balance at Dec. 31, 2024                                 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock, net of issuance costs (in shares)           703,974   510,000                  
Issuance of common stock, net of issuance costs   $ 5,635 $ 1,080     $ 7   $ 5     5,628 $ 1,075          
Exercise of stock options (in shares) 9,757         9,757                      
Exercise of stock options $ 39                   39            
Vesting of restricted common stock (in shares)           1,928                      
Vesting of restricted common stock 25                   25            
Issuance of common stock from the exercise of Pre-funded Warrants (in shares)           200,000                      
Issuance of common stock from the exercise of Pre-funded Warrants 1,016         $ 2         1,014            
Reclassification of liability-classified warrants to equity classified warrants 19,944                   19,944            
Stock-based compensation 1,452                   1,452            
Foreign currency translation adjustment 22                           22    
Net loss $ (51,898)                             (51,898)  
Balance at end of period (in shares) at Dec. 31, 2024 11,029,382         11,043,837                      
Balance at end of period at Dec. 31, 2024 $ (11,312)         $ 110       $ (150) $ 183,004       $ (175) $ (194,101)  
Treasury stock, ending balance (in shares) at Dec. 31, 2024 (14,455)                 (14,455)